SLC6A3 and attention deficit-hyperactivity disorder: In particular, SLC6A3 has been well implicated in the etiology and treatment of attention deficit hyperactivity disorder (ADHD)[16–22] but human genetic association studies with the 3’VNTR could not obtain consistent positive signals[23–25].